{"id":3670,"date":"2023-06-16T00:25:11","date_gmt":"2023-06-15T22:25:11","guid":{"rendered":"https:\/\/www.ipsen.com\/annualreport\/press-releases\/ipsen-delivers-strong-sales-growth-for-the-first-nine-months-and-improves-its-full-year-guidance\/"},"modified":"2023-06-16T00:25:11","modified_gmt":"2023-06-15T22:25:11","slug":"ipsen-delivers-strong-sales-growth-for-the-first-nine-months-and-improves-its-full-year-guidance","status":"publish","type":"press_release","link":"https:\/\/www.ipsen.com\/annualreport\/press-releases\/ipsen-delivers-strong-sales-growth-for-the-first-nine-months-and-improves-its-full-year-guidance\/","title":{"rendered":"Ipsen delivers strong sales growth for the first nine months and improves its full-year guidance"},"content":{"rendered":"

Paris (France), 21\u00a0October 2021\u00a0<\/b>\u2013 Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical group, publishes its sales performance for the third quarter of 2021 and the year to date.<\/p>\n

Sales summary<\/b>
(unaudited IFRS consolidated sales)<\/p>\n\n\n\n\n\n\n\n\n
\u00a0<\/td>\n\u00a0<\/td>\nThird Quarter<\/b><\/td>\n\u00a0<\/td>\nYear To Date<\/b><\/td>\n<\/tr>\n
\u00a0<\/td>\n2021<\/b><\/td>\n2020<\/b><\/td>\n% change<\/b><\/td>\n\u00a0<\/td>\n2021<\/b><\/td>\n2020<\/b><\/td>\n% change<\/b><\/td>\n<\/tr>\n
\u00a0<\/td>\n\u20acm<\/b><\/td>\n\u20acm<\/b><\/td>\nActual<\/b><\/td>\nCER<\/b>1<\/sup><\/td>\n\u00a0<\/td>\n\u20acm<\/b><\/td>\n\u20acm<\/b><\/td>\nActual<\/b><\/td>\nCER<\/b>1<\/sup><\/td>\n<\/tr>\n
\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n<\/tr>\n
Specialty Care<\/td>\n\u00a0<\/td>\n667.8<\/td>\n580.5<\/td>\n15.0%<\/td>\n15.1%<\/td>\n\u00a0<\/td>\n1,912.3<\/td>\n1,747.6<\/td>\n9.4%<\/td>\n12.5%<\/td>\n<\/tr>\n
Consumer Healthcare<\/td>\n\u00a0<\/td>\n59.6<\/td>\n52.8<\/td>\n12.8%<\/td>\n12.2%<\/td>\n\u00a0<\/td>\n165.5<\/td>\n154.0<\/td>\n7.5%<\/td>\n9.8%<\/td>\n<\/tr>\n
Total Sales<\/b><\/td>\n\u00a0<\/td>\n727.4<\/b><\/td>\n633.3<\/b><\/td>\n14.9%<\/b><\/td>\n14.9%<\/b><\/td>\n\u00a0<\/td>\n2,077.7<\/b><\/td>\n1,901.6<\/b><\/td>\n9.3%<\/b><\/td>\n12.3%<\/b><\/td>\n<\/tr>\n<\/table>\n

Highlights<\/b><\/p>\n